Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage.

Masarone M, Rosato V, Aglitti A, Bucci T, Caruso R, Salvatore T, Sasso FC, Tripodi MF, Persico M.

PLoS One. 2017 Jun 1;12(6):e0178473. doi: 10.1371/journal.pone.0178473. eCollection 2017.

2.

Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.

Durante-Mangoni E, Pafundi PC, Ravasio V, Barbaro F, Bassetti M, Chinello P, Falcone M, Pasticci MB, Scotton PG, Stellini R, Tripodi MF, Utili R, Rizzi M.

Infection. 2016 Aug;44(4):467-74. doi: 10.1007/s15010-015-0870-y. Epub 2016 Jan 19.

PMID:
26780903
3.

In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.

Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E, Fowler VG Jr, Gordon D, Grossi P, Hannan M, Hoen B, Muñoz P, Rizk H, Kanj SS, Selton-Suty C, Sexton DJ, Spelman D, Ravasio V, Tripodi MF, Wang A; International Collaboration on Endocarditis–Prospective Cohort Study Investigators.

JAMA Intern Med. 2013 Sep 9;173(16):1495-504. doi: 10.1001/jamainternmed.2013.8203. Erratum in: JAMA Intern Med. 2013 Oct 28;173(19):1846.

PMID:
23857547
4.

Current trends in the management of cardiac implantable electronic device (CIED) infections.

Durante-Mangoni E, Mattucci I, Agrusta F, Tripodi MF, Utili R.

Intern Emerg Med. 2013 Sep;8(6):465-76. doi: 10.1007/s11739-012-0797-6. Epub 2012 Jun 29. Review.

PMID:
22744804
5.

[Management of infections from cardiac implantable electronic devices: recommendations from a study panel].

Durante Mangoni E, Carbonara S, Iacobello C, Tripodi MF, Carretta A, Caprioli V, Pellegrino P, Di Biase M, Favale S, Santantonio TA, Esposito S, Nappi G, Angarano G, Utili R.

Infez Med. 2011 Dec;19(4):207-23. Review. Italian.

6.

Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.

Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A.

JAMA. 2011 Nov 23;306(20):2239-47. doi: 10.1001/jama.2011.1701.

7.

Molecular epidemiology and mechanisms of rifampicin resistance in Acinetobacter baumannii isolates from Italy.

Giannouli M, Di Popolo A, Durante-Mangoni E, Bernardo M, Cuccurullo S, Amato G, Tripodi MF, Triassi M, Utili R, Zarrilli R.

Int J Antimicrob Agents. 2012 Jan;39(1):58-63. doi: 10.1016/j.ijantimicag.2011.09.016. Epub 2011 Nov 3.

PMID:
22055530
8.

In vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis.

Tripodi MF, Durante-Mangoni E, Fortunato R, Cuccurullo S, Mikami Y, Farina C, Utili R.

Transpl Infect Dis. 2011 Aug;13(4):335-43. doi: 10.1111/j.1399-3062.2010.00588.x. Epub 2010 Dec 13.

PMID:
21156012
9.

Management of Gram-negative and fungal endocarditis.

Durante-Mangoni E, Tripodi MF, Albisinni R, Utili R.

Int J Antimicrob Agents. 2010 Dec;36 Suppl 2:S40-5. doi: 10.1016/j.ijantimicag.2010.11.012. Epub 2010 Dec 3. Review.

PMID:
21129927
10.

Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.

Bae IG, Federspiel JJ, Miró JM, Woods CW, Park L, Rybak MJ, Rude TH, Bradley S, Bukovski S, de la Maria CG, Kanj SS, Korman TM, Marco F, Murdoch DR, Plesiat P, Rodriguez-Creixems M, Reinbott P, Steed L, Tattevin P, Tripodi MF, Newton KL, Corey GR, Fowler VG Jr; International Collaboration on Endocarditis-Microbiology Investigator.

J Infect Dis. 2009 Nov 1;200(9):1355-66. doi: 10.1086/606027.

11.

Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon.

Adinolfi LE, Durante-Mangoni E, Salzillo M, Marrone A, Tripodi MF, Restivo L, Merola A, Zampino R, Ruggiero G.

Intern Emerg Med. 2009 Dec;4(6):485-90. doi: 10.1007/s11739-009-0290-z.

PMID:
19649689
12.

Rhodococcus equi endocarditis in immunocompetent hosts: report of the first two cases.

Tripodi MF, Vigo D, Durante-Mangoni E, Lifschitz A, Corey GR, Stryjewski ME, Utili R, Pryluka D; International Collaboration on Endocarditis Prospective Cohort Study.

Int J Antimicrob Agents. 2009 Nov;34(5):496-7. doi: 10.1016/j.ijantimicag.2009.06.002. Epub 2009 Jul 9. No abstract available.

PMID:
19589660
13.

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.

Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH; International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators.

Arch Intern Med. 2009 Mar 9;169(5):463-73. doi: 10.1001/archinternmed.2008.603.

14.

Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.

Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Koneçny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miró JM, van der Meer JT, Utili R; International Collaboration on Endocarditis Prospective Cohort Study Group.

Arch Intern Med. 2008 Oct 27;168(19):2095-103. doi: 10.1001/archinte.168.19.2095.

PMID:
18955638
15.

Phylogenetic analysis of viridans group streptococci causing endocarditis.

Simmon KE, Hall L, Woods CW, Marco F, Miro JM, Cabell C, Hoen B, Marin M, Utili R, Giannitsioti E, Doco-Lecompte T, Bradley S, Mirrett S, Tambic A, Ryan S, Gordon D, Jones P, Korman T, Wray D, Reller LB, Tripodi MF, Plesiat P, Morris AJ, Lang S, Murdoch DR, Petti CA; International Collaboration on Endocarditis Microbiology Investigators.

J Clin Microbiol. 2008 Sep;46(9):3087-90. doi: 10.1128/JCM.00920-08. Epub 2008 Jul 23.

16.

Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.

Zampino R, Ingrosso D, Durante-Mangoni E, Capasso R, Tripodi MF, Restivo L, Zappia V, Ruggiero G, Adinolfi LE.

J Viral Hepat. 2008 Oct;15(10):740-6. doi: 10.1111/j.1365-2893.2008.00994.x. Epub 2008 May 14.

PMID:
18482281
17.

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE.

J Hepatol. 2008 Mar;48(3):399-406. doi: 10.1016/j.jhep.2007.10.011. Epub 2007 Dec 3.

PMID:
18164507
18.

Nocardia brasiliensis in Italy: a nine-year experience.

Farina C, Andrini L, Bruno G, Sarti M, Tripodi MF, Utili R, Boiron P.

Scand J Infect Dis. 2007;39(11-12):969-74.

PMID:
18027278
19.

Infection of intravascular prostheses: how to treat other than surgery.

Utili R, Durante-Mangoni E, Tripodi MF.

Int J Antimicrob Agents. 2007 Nov;30 Suppl 1:S42-50. Epub 2007 Sep 14. Review.

PMID:
17869069
20.
21.

Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.

Zarrilli R, Casillo R, Di Popolo A, Tripodi MF, Bagattini M, Cuccurullo S, Crivaro V, Ragone E, Mattei A, Galdieri N, Triassi M, Utili R.

Clin Microbiol Infect. 2007 May;13(5):481-9.

22.

Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.

Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE.

Aliment Pharmacol Ther. 2006 Nov 1;24(9):1349-57.

23.

Inhaled tobramycin in children with acute bacterial rhinopharyngitis.

Varricchio A, Tricarico D, De Lucia A, Utili R, Tripodi MF, Miraglia Del Giudice M, Capasso M, Sabatino G, Sgarrella M, Marseglia GL, Ciprandi G.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):131-40.

PMID:
16569351
24.

Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.

Zarrilli R, Tripodi MF, Di Popolo A, Fortunato R, Bagattini M, Crispino M, Florio A, Triassi M, Utili R.

J Antimicrob Chemother. 2005 Nov;56(5):827-35. Epub 2005 Sep 26.

PMID:
16186168
25.

Molecular epidemiology of Streptococcus bovis causing endocarditis and bacteraemia in Italian patients.

Tripodi MF, Fortunato R, Utili R, Triassi M, Zarrilli R.

Clin Microbiol Infect. 2005 Oct;11(10):814-9.

26.

Hepatic cryptococcosis in a heart transplant recipient.

Utili R, Tripodi MF, Ragone E, Casillo R, Pasquale G, De Santo L, Esposito S.

Transpl Infect Dis. 2004 Mar;6(1):33-6.

PMID:
15225225
27.

Streptococcus bovis endocarditis and its association with chronic liver disease: an underestimated risk factor.

Tripodi MF, Adinolfi LE, Ragone E, Durante Mangoni E, Fortunato R, Iarussi D, Ruggiero G, Utili R.

Clin Infect Dis. 2004 May 15;38(10):1394-400. Epub 2004 Apr 28.

PMID:
15156477
28.

Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients.

Casillo R, Grimaldi M, Ragone E, Maiello C, Marra C, De Santo L, Amarelli C, Romano G, Della Corte A, Portella G, Tripodi MF, Fortunato R, Cotrufo M, Utili R.

Transplant Proc. 2004 Apr;36(3):651-3.

PMID:
15110622
29.

Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: effects of hepatitis B virus co-infection and interferon treatment.

Zampino R, Marrone A, Durante Mangoni E, Santarpia L, Sica A, Tripodi MF, Utili R, Ruggiero G, Adinolfi LE.

J Med Virol. 2004 May;73(1):33-7.

PMID:
15042645
30.

Risk factors for "major" embolic events in hospitalized patients with infective endocarditis.

Durante Mangoni E, Adinolfi LE, Tripodi MF, Andreana A, Gambardella M, Ragone E, Precone DF, Utili R, Ruggiero G.

Am Heart J. 2003 Aug;146(2):311-6.

PMID:
12891201
31.
32.

First definite case of aortic valve endocarditis due to Moraxella phenylpyruvica.

Tripodi MF, Adinolfi LE, Rosario P, Ragone E, Utili R.

Eur J Clin Microbiol Infect Dis. 2002 Jun;21(6):480-2. Epub 2002 Jun 11.

PMID:
12111609
33.

Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies.

Tripodi MF, Adinolfi LE, Andreana A, Sarnataro G, Durante Mangoni E, Gambardella M, Casillo R, Farina C, Utili R.

Clin Transplant. 2001 Dec;15(6):415-20.

PMID:
11737119
34.

Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

Adinolfi LE, Utili R, Andreana A, Tripodi MF, Marracino M, Gambardella M, Giordano M, Ruggiero G.

Dig Dis Sci. 2001 Aug;46(8):1677-83.

PMID:
11508667
35.

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.

Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G.

Hepatology. 2001 Jun;33(6):1358-64.

PMID:
11391523
36.

Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis.

Adinolfi LE, Giordano MG, Andreana A, Tripodi MF, Utili R, Cesaro G, Ragone E, Durante Mangoni E, Ruggiero G.

Br J Haematol. 2001 Jun;113(3):590-5.

PMID:
11380442
37.

Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.

Tripodi MF, Andreana A, Sarnataro G, Ragone E, Adinolfi LE, Utili R.

Eur J Clin Microbiol Infect Dis. 2001 Jan;20(1):73-5. No abstract available.

PMID:
11245333
38.

Improved outcome of pulmonary aspergillosis in heart transplant recipients with early diagnosis and itraconazole treatment.

Utili R, Zampino R, De Vivo F, Maiello C, Andreana A, Mormone G, Marra C, Tripodi MF, Sarnataro G, Cione P, Cuccurullo S, Cotrufo M.

Clin Transplant. 2000 Aug;14(4 Pt 1):282-6.

PMID:
10945197
39.

Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.

Adinolfi LE, Utili R, Andreana A, Tripodi MF, Rosario P, Mormone G, Ragone E, Pasquale G, Ruggiero G.

Eur J Gastroenterol Hepatol. 2000 Mar;12(3):299-304.

PMID:
10750650
41.

Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci.

Tripodi MF, Locatelli A, Adinolfi LE, Andreana A, Utili R.

Eur J Clin Microbiol Infect Dis. 1998 Oct;17(10):734-6.

PMID:
9865990
42.

In-vitro activity of combined ampicillin and ciprofloxacin against high-level gentamicin-resistant strains of Enterococcus faecium: influence of the medium on susceptibility test results.

Tripodi MF, Locatelli A, Rambaldi A, Rosario P, Utili R.

J Antimicrob Chemother. 1998 Jan;41(1):139-40. No abstract available.

PMID:
9511052
43.
44.

Different susceptibility of coagulase-positive and coagulase-negative staphylococci to ciprofloxacin.

Utili R, Tripodi MF, Rosario P, Andreana A, Locatelli A, Rambaldi A, Florio A.

New Microbiol. 1996 Oct;19(4):309-14.

PMID:
8914131
45.

Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.

Tripodi MF, Utili R, Rambaldi A, Locatelli A, Rosario P, Florio A, Ruggiero G.

J Antimicrob Chemother. 1996 Apr;37(4):727-36.

PMID:
8722538
46.

[Enterococcal endocarditis: clinical and microbiological features of our series].

Utili R, Tripodi MF, Andreana A, Adinolfi LE, Rosario P, Florio A.

Infez Med. 1996;4(3):137-42. Italian.

PMID:
14976434
47.

Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study.

Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi MF, Ruggiero G.

Ital J Gastroenterol. 1996 Jan;28(1):1-9.

PMID:
8743066
48.

Therapeutic index of taurocholate or tauroursodeoxycholate in experimental drug-induced cholestasis.

Utili R, Adinolfi LE, Tripodi MF.

Ital J Gastroenterol. 1995 Jul-Aug;27(6):332-4.

PMID:
8563000
49.

Resistance to aminoglycosides and other antibiotics among clinical isolates of Enterococcus spp.

Tripodi MF, Rambaldi A, Utili R, Rosario P, Attanasio V, Locatelli A, Adinolfi LE, Andreana A, Florio A, Ruggiero G.

New Microbiol. 1995 Jul;18(3):319-23.

PMID:
7553370
50.

Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.

Utili R, Rambaldi A, Tripodi MF, Andreana A.

Infection. 1995 May-Jun;23(3):182-3.

PMID:
7499009

Supplemental Content

Loading ...
Support Center